Metabolic markers and thinking problems in children with HIV
Part of Immune system & allergy, Infections clinical trials.
This study looks at blood samples from children who are part of the Pediacam III study to see if certain chemicals in the blood are linked to thinking or memory problems. The goal is to find better ways to predict or understand these issues in children living with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child who took part in the Pediacam III study.
- You participated in the PediacamDev thinking and learning assessments.
- You had your blood tested for this study.
- You have blood samples from specific check-ups during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research compares the immune system in the gut lining, spinal fluid, lymph nodes, and blood between people living with HIV and people not living with HIV. Results may help scientists understand how immunity works and how it differs with HIV.
This trial compares new HIV medicines to help children and teens who have HIV and are either starting treatment or whose current treatment isn't working. The goal is to find better ways to control the virus and keep kids healthy.
This study looks at how thinking and memory change over time in adults with HIV and compares them with adults without HIV. Researchers will do regular visits and brain/cognitive testing to understand what affects thinking and memory and to learn what might help.
This study looks at why some HIV-positive children who started treatment early may have a negative HIV antibody test. It uses stored blood samples from children who were in the Pediacam III study to better understand the immune response.
This study looks at how HIV and its treatment might affect thinking and memory in teenagers. If you are a teen with HIV getting care at Baylor Clinic, or a teen without HIV, you might be able to join.
This study uses PET and MRI scans, plus blood tests and memory/thinking questionnaires, to understand what drives brain problems in people living with HIV even during treatment. It may help researchers learn why symptoms happen and how treatment relates to brain function.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.